Khiron Life Sciences (Khiron Life Sciences) Cyclically Adjusted PS Ratio : 0.13 (As of Jun. 09, 2024)

View and export this data going back to 2018. Start your Free Trial

What is Khiron Life Sciences Cyclically Adjusted PS Ratio?

As of today (2024-06-09), Khiron Life Sciences's current share price is $0.009. Khiron Life Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2022 was $0.07. Khiron Life Sciences's Cyclically Adjusted PS Ratio for today is 0.13.

The historical rank and industry rank for Khiron Life Sciences's Cyclically Adjusted PS Ratio or its related term are showing as below:

KHRNF's Cyclically Adjusted PS Ratio is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 2.05
* Ranked among companies with meaningful Cyclically Adjusted PS Ratio only.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Khiron Life Sciences's adjusted revenue per share data for the three months ended in Sep. 2022 was $0.012. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $0.07 for the trailing ten years ended in Sep. 2022.

Shiller PE for Stocks: The True Measure of Stock Valuation

Khiron Life Sciences Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Khiron Life Sciences's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Khiron Life Sciences Cyclically Adjusted PS Ratio Chart

Khiron Life Sciences Annual Data

Trend

May12

May13

May14

May15

May16

May17

Dec18

Dec19

Dec20

Dec21

Cyclically Adjusted PS Ratio

Get a 7-Day Free Trial

Khiron Life Sciences Quarterly Data
	Nov17	Feb18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Cyclically Adjusted PS Ratio	Get a 7-Day Free Trial															-	-	2.93	1.30	1.10

Competitive Comparison of Khiron Life Sciences's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Khiron Life Sciences's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Khiron Life Sciences's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Khiron Life Sciences's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Khiron Life Sciences's Cyclically Adjusted PS Ratio falls into.

Khiron Life Sciences Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Khiron Life Sciences's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio	=	Share Price	/	Cyclically Adjusted Revenue per Share
	=	0.009	/	0.07
	=	0.13

Khiron Life Sciences's Cyclically Adjusted Revenue per Share for the quarter that ended in Sep. 2022 is calculated as:

For example, Khiron Life Sciences's adjusted Revenue per Share data for the three months ended in Sep. 2022 was:

Adj_RevenuePerShare	=	Revenue per Share	/	CPI of Sep. 2022 (Change)	*	Current CPI (Sep. 2022)
	=	0.012	/	120.6479	*	120.6479
	=	0.012

Current CPI (Sep. 2022) = 120.6479.

Khiron Life Sciences Quarterly Data

	Revenue per Share	CPI	Adj_RevenuePerShare
201211	0.000	96.313	0.000
201302	0.000	96.945	0.000
201305	0.000	97.182	0.000
201308	0.000	97.261	0.000
201311	0.000	97.182	0.000
201402	0.000	98.051	0.000
201405	0.000	99.394	0.000
201408	0.000	99.315	0.000
201411	0.000	99.078	0.000
201502	0.000	99.078	0.000
201505	0.000	100.263	0.000
201508	0.000	100.579	0.000
201511	0.000	100.421	0.000
201602	0.000	100.421	0.000
201605	0.000	101.765	0.000
201608	0.000	101.686	0.000
201611	0.000	101.607	0.000
201702	0.000	102.476	0.000
201705	0.000	103.108	0.000
201708	0.000	103.108	0.000
201711	0.000	103.740	0.000
201802	0.000	104.688	0.000
201806	0.000	105.557	0.000
201809	0.000	105.636	0.000
201812	0.009	105.399	0.010
201903	0.021	106.979	0.024
201906	0.017	107.690	0.019
201909	0.018	107.611	0.020
201912	0.016	107.769	0.018
202003	0.012	107.927	0.013
202006	0.011	108.401	0.012
202009	0.012	108.164	0.013
202012	0.015	108.559	0.017
202103	0.015	110.298	0.016
202106	0.015	111.720	0.016
202109	0.016	112.905	0.017
202112	0.016	113.774	0.017
202203	0.020	117.646	0.021
202206	0.019	120.806	0.019
202209	0.012	120.648	0.012

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Khiron Life Sciences (OTCPK:KHRNF) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.

Khiron Life Sciences Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Khiron Life Sciences's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Khiron Life Sciences (Khiron Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Khiron Life Sciences Corp (OTCPK:KHRNF) » Definitions » Cyclically Adjusted PS Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

2300 - 500 Burrard Street, Vancouver, BC, CAN, V6C 2B5

Website

https://www.khiron.ca

Khiron Life Sciences Corp is a vertically integrated medical company with core operations in Latin America and Europe, The company's platform leverages medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The company has a presence in Mexico, Peru, Germany, the United Kingdom, and Brazil.